.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Chinese Patent Office
Medtronic
Farmers Insurance
US Department of Justice
Novartis
Accenture
Deloitte
Covington
Moodys

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074806

« Back to Dashboard
NDA 074806 describes PERMETHRIN, which is a drug marketed by Actavis Labs, Actavis Mid Atlantic, and Perrigo New York, and is included in four NDAs. It is available from twenty-four suppliers. Additional details are available on the PERMETHRIN profile page.

The generic ingredient in PERMETHRIN is permethrin. There are five drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the permethrin profile page.

Summary for NDA: 074806

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 074806

Ingredient-typePyrethrins

Suppliers and Packaging for NDA: 074806

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PERMETHRIN
permethrin
CREAM;TOPICAL 074806 ANDA Actavis Mid Atlantic LLC 0472-0242 0472-0242-60 1 TUBE in 1 CARTON (0472-0242-60) > 60 g in 1 TUBE
PERMETHRIN
permethrin
CREAM;TOPICAL 074806 ANDA REMEDYREPACK INC. 70518-0533 70518-0533-0 60 g in 1 TUBE (70518-0533-0)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength5%
Approval Date:Jan 23, 1998TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Julphar
Cipla
Merck
Harvard Business School
Medtronic
Baxter
Novartis
Healthtrust
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot